Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four
epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence …

In the past decade, the emergence of machine learning (ML) applications has led to
significant advances towards implementation of personalised medicine approaches for …

The development of artificial intelligence (AI) has increased dramatically in the last 20 years,
with clinical applications progressively being explored for most of the medical specialties …

Inflammatory bowel disease (IBD) is a complex and multifaceted disorder of the
gastrointestinal tract that is increasing in incidence worldwide and associated with …

Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and
manage inflammatory bowel disease (IBD). Advances in the machine learning …

Artificial intelligence (AI) refers to computer-based methodologies which use data to teach a
computer to solve pre-defined tasks; these methods can be applied to identify patterns in …

Abstract Background Many patients with Crohn's disease (CD) who lose response to the
standard ustekinumab dose interval of every 8 weeks (q8w) undergo dose intensification to …

Background Inflammatory bowel disease (IBD) is a gastrointestinal chronic disease with an
unpredictable disease course. Computational methods such as machine learning (ML) have …

Abstract Background The SI-CURA project (Soluzioni Innovative per la gestione del
paziente e il follow up terapeutico della Colite UlceRosA) is an Italian initiative aimed at the …

In the past decade, several new therapies with different mechanisms of action have been
approved for the management of moderate to severe Crohn's disease. However, there is …